GlassScriptPhysician profile
Spencer Thomas Whitt
NPI 1790265882
$2,066.16
in general payments reported to CMS, 2019-2025
11 companies · $706 in 2025
The $706 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $16.08 · 2021: $22.05 · 2022: $159 · 2023: $333 · 2024: $461 · 2025: $706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,499.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $671.80 | 2019-2025 | Clariti Contact Lens, Misight Contact Lens, Myday Contact Lens |
| Bausch & Lomb Americas INC. | $503.80 | 2024-2025 | Infuse, Vyzulta, Xiidra |
| Alcon Vision LLC | $360.74 | 2019-2025 | Total30, Rocklatan |
| Abbvie INC. | $156.21 | 2023-2025 | Alphagan P, Vuity, Lumigan |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $141.14 | 2019 | |
| Kala Pharmaceuticals, INC. | $69.87 | 2019 | |
| Thea Pharma INC. | $51.69 | 2023-2025 | Iyuzeh |
| Novartis Pharmaceuticals Corporation | $45.19 | 2022-2023 | |
| Oyster Point Pharma, INC. | $32.67 | 2022-2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $22.05 | 2021 | |
| Shire North American Group INC | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spencer Whitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.